OSS-128167-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
OSS-128167-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
OSS-128167-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEOSS_128167Cat. No.: HY-107454CAS No.: 887686-02-4分式: CHNO分量: 366.32作靶點(diǎn): Sirtuin作通路: Cell Cycle/DNA Damage; Epigenetics儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 103.3 mg/mL (281.99 mM;

2、 Need ultrasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.7299 mL 13.6493 mL 27.2985 mL5 mM 0.5460 mL 2.7299 mL 5.4597 mL10 mM 0.2730 mL 1.3649 mL 2.7299 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn) 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前?qǐng)先配制澄清的儲(chǔ)備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配

3、,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.82 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (6.82 mM); Clear solutionBIOLOGICAL ACTIVITY1/2 Master of Small Molecules 您邊的抑制劑師www.Med

4、ChemE物活性 OSS_128167個(gè)選擇性 SIRT6 抑制劑,對(duì)于 SIRT6,SIRT1 和 SIRT2 的 IC50 值分別為 89,1578 和 751 M。IC50 & Target SIRT6 SIRT2 SIRT189 M (IC50) 751 M (IC50) 1578 M (IC50)體外研究 OSS_128167 is a selective SIRT6 inhibitor with IC50s of 89, 1578 and 751 M for SIRT6, SIRT1 and SIRT2,respectively. OSS_128167 inhibits SIRT6

5、 in the micromolar range, but shows promising selectivity, since itsIC50 value for SIRT6 is approximately 17 times lower compare to the IC50 for SIRT1 and 9 times lowercompare to SIRT2 1. OSS_128167 (200 M) induces chemosensitization in primary multiple myeloma (MM)cells (NCI-H929), as well as in me

6、lphalan-resistant (LR-5) and doxorubicin-resistant (Dox40) MM cell lines2.PROTOCOLKinase Assay 1 TNF-a levels in supernatants from cells incubated for 18 h in the presence or absence of OSS_128167 (100M, final concentration) are measured by a commercially available ELISA kit according to the manufac

7、turersinstructions 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 Glucose uptake is evaluated using a fluorescent D-glucose analog, 2-NBDG, in L6 cells incubated for 18 h inthe presence or absence of OSS_128167 (100 M, final concentratio

8、n) 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Parenti MD, et al. Discovery of novel and selective SIRT6 inhibitors. J Med Chem. 2014 Jun 12;57(11):4796-804.2. Cea M, et al. Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells. Blood. 2016 Mar3;127(9):1138-50.McePdfHeightCaution: Product has not been fully validated for medical applicat

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論